Navigation Links
Bioniche Invited to Participate in Canadian Beef Value Chain Roundtable
Date:2/3/2009

           - President of Bioniche Food Safety an invited speaker -

BELLEVILLE, ON, Feb. 3 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, announced that its President of Bioniche Food Safety, Rick Culbert, is today participating in a Canadian Beef Value Chain Roundtable in Gatineau, Quebec. The two-day Roundtable involves representatives from regulatory authorities, ranchers, feedlot operators, processors, retail and food service representatives, feed suppliers and others. They are meeting to develop a strategy focused on improving competitiveness of the Canadian beef industry through market access and development, the regulatory environment, research and innovation and information transfer.

In his presentation to the Roundtable, Mr. Culbert will be sharing information about the Company's Econiche(TM) cattle vaccine, the world's first vaccine developed to reduce the shedding by cattle of Escherichia coli (E. coli) O157. Econiche is fully licensed for sale in Canada by the Canadian Food Inspection Agency (CFIA).

The vaccine has the potential to significantly reduce the amount of E. coli O157 shed into the environment by beef and dairy cattle and, in turn, reduce the risk to human health. An outbreak of human infection with E. coli O157 last fall in North Bay, Ontario, Canada involved 250 people reporting symptoms 50 lab-confirmed cases of human illness including one case of Haemolytic Uremic Syndrome (HUS). The illnesses were associated with a Harvey's Restaurant in that community.

Most strains of E. coli are harmless but some, like O157:H7, can cause severe illness and even be fatal when ingested by humans from contaminated meat, vegetables or water. Vaccination of cattle with Econiche can help reduce the risk of food and waterborne contamination with E. coli O157. Cows carry E. coli O157:H7 but they don't get sick. Where the disease comes from is people encountering contaminated food or water, usually from cow feces.

On-farm interventions to reduce the shedding of E. coli O157 by cattle, such as simple vaccination of cattle with Econiche, have the potential to reduce food and water contamination and the consequences associated with human infection with the deadly bacteria. Clinical trials conducted with Econiche have shown a significant reduction in the amount of E. coli shed in the manure of vaccinated cows.

"At today's Beef Value Chain Roundtable, I will be discussing the collaborative Canadian partnership that led to the development of Econiche," said Rick Culbert, President of Bioniche Food Safety. "I will also share information about the opportunity that vaccination of Canadian cattle represents beyond protecting public health, that is, a potential enhancement of the competitiveness of Canadian beef in export markets, where the vaccine is not yet available to producers."

About the Beef Value Chain Roundtable

The Beef Value Chain Roundtable was launched in January, 2003 and emerged as a key vehicle for helping ensure a coordinated response to Bovine Spongiform Encephalopathy (BSE) and as a key focal point for various working groups to engage with representatives of the entire beef value chain. Now more focused on long-term issues, membership on the beef roundtable includes ranchers, feedlot operators, processors, retail and food service representatives, feed suppliers and others.

About Bioniche Life Sciences Inc.

Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs approximately 200 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety. The Company's primary goal is to develop proprietary cancer therapies supported by revenues from marketed products in human and animal health. Bioniche has been named one of the Top 50 Best Small and Medium-Sized Employers in Canada for 2009. For more information, please visit www.Bioniche.com.

Except for historical information, this news release may contain forward-looking statements that reflect the Company's current expectation regarding future events. These forward-looking statements involve risk and uncertainties, which may cause, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process, and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting.


'/>"/>
SOURCE Bioniche Life Sciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Bioniche Named One of the Top 50 Best Small and Medium Employers in Canada
2. Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile
3. Bioniche Reports Fiscal 2009 First Quarter
4. Bioniche Allows Conversion of Portion of Revolving Credit Facility
5. Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary
6. Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference
7. Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production
8. Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia
9. Bioniche Presents Pre-Clinical Research at Two International Conferences
10. Bioniche Updates re: Mycobacterial Cell Wall Technology Platform
11. Bioniche Reports Fiscal 2008 Third Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of Eating ... excellence for the field of eating disorders, announces the opening of early registration ... Orlando, Florida at the Omni Resort at ChampionsGate. , The annual ...
(Date:10/13/2017)... ... 2017 , ... Lori R. Somekh, founder of the Law Office of ... elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain ... to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of ... collection of specialty vendors and unique items from across the nation, this holiday-themed event ... wellness services offered by the VNA. The boutique will be open Saturday, November ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  True Health, a ... amplified its effort during National Breast Cancer Awareness ... cancer risks. ... Oncology calculated that more than 10 million American ... mutations in BRCA1 or BRCA2 and have not had ...
(Date:10/5/2017)... , Oct. 5, 2017  In response to ... Oral and Maxillofacial Surgeons (AAOMS) released prescribing recommendations ... to be used as a first-line therapy to ... Recognizing the value ... White Paper "Opioid Prescribing: Acute and Postoperative Pain ...
(Date:10/2/2017)... INDIANAPOLIS , Oct. 2, 2017  Eli Lilly ... its financial results for the third quarter of 2017 ... a conference call on that day with the investment ... performance. The conference call will begin at ... public can access a live webcast of the conference ...
Breaking Medicine Technology: